Press Releases on April 28, 2020 - EIN Presswire - Press Release Distribution Service

Published on April 28, 2020 - 10:30 GMT

Amerant Bancorp Inc. Reports First Quarter Results and Provides Business Update Impact From COVID-19 Pandemic

CORAL GABLES, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) today reported first quarter 2020 net income of $3.4 million, 74.9% lower than the $13.5 million reported in the three months …

Distribution channels:

Published on April 28, 2020 - 10:30 GMT

Gold-Silver Geochemical Anomalies Defined by Soil Sampling Program at El Zanjon, Argentina

VANCOUVER, British Columbia, April 28, 2020 (GLOBE NEWSWIRE) -- Rugby Mining Limited (“Rugby” or the “Company”) (TSX-V: RUG) is pleased to report on the results of a soil sampling program recently completed on the El Zanjon gold-silver project in Santa …

Distribution channels:

Published on April 28, 2020 - 10:23 GMT

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Multiple Sclerosis, Relapsing-Remitting, ...

Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:23 GMT

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Multiple Sclerosis, Relapsing-Remitting, ...

Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:19 GMT

Human medicines European public assessment report (EPAR): Fingolimod Mylan, fingolimod, Multiple Sclerosis, Relapsing-Remitting, ...

Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and adequate course …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:19 GMT

Human medicines European public assessment report (EPAR): Fingolimod Mylan, fingolimod, Multiple Sclerosis, Relapsing-Remitting, ...

Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and adequate course …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:18 GMT

Nanto Cleantech Inc recibe una nueva Patente por parte de US Patent patentes de pinturas y recubrimientos en nanoarcilla

Alta propiedad de desinfección debido a la composición del tratamiento químico de la nanoarcilla basada en el catión de amonio cuaternario. NYC, NY, USA, April 28, 2020 /⁨EINPresswire.com⁩/ -- Nanto Cleantech Inc. recibe una nueva Patente por parte de la …

Distribution channels: Chemical Industry, Emergency Services ...

Published on April 28, 2020 - 10:17 GMT

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Asthma,...

Zimbus Breezhaler is an asthma medicine for inhalation. It is used for maintenance (regular) treatment in adults whose asthma is not controlled well enough with inhaled long-acting beta-2 agonist together with a high dose of an inhaled corticosteroid. It …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:17 GMT

Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Asthma,...

Zimbus Breezhaler is an asthma medicine for inhalation. It is used for maintenance (regular) treatment in adults whose asthma is not controlled well enough with inhaled long-acting beta-2 agonist together with a high dose of an inhaled corticosteroid. It …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:12 GMT

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Anemia;Myelodysplastic Syndromes;beta-...

The most common side effects with Reblozyl in patients with myelodysplastic syndromes (which may affect more than 15 in 100 people) are tiredness, diarrhoea, weakness, nausea (feeling sick), dizziness, back pain and headache. The most common serious or …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:12 GMT

Human medicines European public assessment report (EPAR): Reblozyl, luspatercept, Anemia;Myelodysplastic Syndromes;beta-...

The most common side effects with Reblozyl in patients with myelodysplastic syndromes (which may affect more than 15 in 100 people) are tiredness, diarrhoea, weakness, nausea (feeling sick), dizziness, back pain and headache. The most common serious or …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:08 GMT

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), ...

Byannli (previously Paliperidone Janssen-Cilag International) is an antipsychotic medicine used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised on treatment with injections of paliperidone given every …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:08 GMT

Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), ...

Byannli (previously Paliperidone Janssen-Cilag International) is an antipsychotic medicine used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised on treatment with injections of paliperidone given every …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:04 GMT

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Diabetes Mellitus, Date of ...

The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Insulin aspart Sanofi has a highly similar structure, purity and biological activity to NovoRapid and is distributed in the body in the same way. In …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:04 GMT

Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Diabetes Mellitus, Date of ...

The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Insulin aspart Sanofi has a highly similar structure, purity and biological activity to NovoRapid and is distributed in the body in the same way. In …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 28, 2020 - 10:03 GMT

International Monetary Fund (IMF) Gabon agreement a testament to Gabon's likely quick recovery post COVID-19 and oil crash

On April 9th, the IMF and the Government of Gabon reached an agreement for a $147m facility that is meant to help Gabon address the challenges that have arisen due to the global Covid-19 pandemic. Prior to the pandemic, Gabon’s economy, that is driven …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 28, 2020 - 10:00 GMT

Ragnarok Origin (Mobile) Available for Pre-Registration and CBT in Korea and Ragnarok Online (PC) CBT in Thailand

Seoul, April 28, 2020 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, today announced that the company has officially started pre-registration for Ragnarok Origin, a new …

Distribution channels: IT Industry

Published on April 28, 2020 - 10:00 GMT

Torex Gold Reports 2019 Year-End Mineral Reserves & Resources for El Limón Guajes Complex

TORONTO, April 28, 2020 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports that in 2019, for the Company’s El Limón Guajes (ELG) Complex, total gold reserves declined 9% (approximately 0.22 million ounces). Open pit …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on April 28, 2020 - 10:00 GMT

New Sheraton Hotel Project Funded by CIG Capital Despite Pandemic

ORLANDO, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- CIG Capital (CIG CAP), an alternative investment firm, continues funding for the hospitality industry during the coronavirus pandemic and announces a new 95 million dollar lending project for a new Sheraton …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on April 28, 2020 - 10:00 GMT

Federal Home Loan Bank of San Francisco Announces First Quarter 2020 Operating Results

SAN FRANCISCO, April 28, 2020 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of San Francisco (Bank) today announced its operating results for the first quarter of 2020. The Bank incurred a net loss of $8 million for the first quarter of 2020, compared …

Distribution channels: